Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets

Journal of the National Cancer Institute

Volumn 89, Issue 7, 1997, Pages 506-512

  Reddy, Bandaru S ^a   Rivenson, Abraham ^a   El Bayoumy, Karam ^a   Upadhyaya, Pramod ^a   Pittman, Brian ^a   Rao, Chinthalapally V ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 4 METHOXYBENZYLSELENOCYANATE; AZOXYMETHANE; ORGANOSELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; COLON CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; FAT INTAKE; INCIDENCE; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TOXICITY TESTING;

EID: 0030909726     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.7.506     Document Type: Article

References (38)

1. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editors. Cancer incidence in five continents. Vol VI. IARC Sci Publ No. 120. Lyon: IARC, 1992.
2. Giovannucci E, Willett WC. Dietary factors and risk of colon cancer. Ann Med 1994;26: 443-52.
3. Kune GA. Causes and control of colorectal cancer. Boston: Kluwer Academic Publishers, 1996:69-115.
4. Ready BS. Diet and colon cancer: evidence from human and animal model studies. In: Reddy BS, Cohen LA, editors. Diet, nutrition and cancer: a critical evaluation. Boca Raton (FL): 1996:47-65.
5. Clark LC. The epidemiology of selenium and cancer. Fed Proc 1985;44:2584-9.
6. Ip C. Selenium inhibition of chemical carcinogenesis. Fed Proc 1985;44:2573-8.
7. Jacobs MM, Forst CF, Beams FA. Biochemical and clinical effects of selenium on dimethylhydrazine-induced colon cancer in rats. Cancer Res 1981;41(11 Pt 1):4458-65.
8. El-Bayoumy K. The role of selenium in cancer prevention. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer prevention. Philadelphia: Lippincott, 1991:1-15.
9. Fan AM, Kizer KW. Selenium. Nutritional toxicologic, and clinical aspects. West J Med 1990;153:160-7.
10. Greenwald P, Kelloff GJ, Boone CW, McDonald SS. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol Biomarkers Prev 1995;4:691-702.
11. Nayini JR, Sugie S, El-Bayoumy K, Rao CV, Rigotty J, Sohn OS, et al. Effect of dietary benzylselenocyanate on azoxymethane-induced colon carcinogenesis in male F344 rats. Nutr Cancer 1991;15:129-39.
12. El-Bayoumy K, Chae YH, Upadhyaya P, Meschter C, Cohen LA, Reddy BS. Inhibition of 7.12-dimethylbenz[a]anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound. 1,4-phenylenebis(methylene)selenocyanate. Cancer Res 1992;52:2402-7.
13. El-Bayoumy K, Upadhyaya P, Desai DH, Amin S, Hecht SS. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis-(methylene)selenocyanate. Carcinogenesis 1993;14:1111-3.
14. Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P, El-Bayoumy K. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis-(methylene)selenocyanate. Cancer Res 1992; 52:5635-40.
15. Ip C, El-Bayoumy K, Upadhyaya P, Ganther H, Vadhanavikit S, Thompson H. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis 1994;15:187-92.
16. 14C]benzyl selenocyanate in the F344 rats. Chem Res Toxicol 1991;4:560-5.
17. Reddy BS, Upadhyaya P, Simi B, Rao CV. Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis. Anticancer Res 1994;14:2509-14.
18. Reddy BS, Wynn TT, El-Bayoumy K, Upadhyaya P, Fiala E, Rao CV. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer. Anti-cancer Res 1996;16:1123-7.
19. Reddy BS, Burill C, Rigotty J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51:487-91.
20. Tamura Y, Adachi M, Kawasaki I, Kita Y. Selenocyanation using a combined reagent of diphenylphosphine and selenocyanogen, a new and simple synthesis of alkyselenocyanates and symmetrical alkyl diselenides from alcohols. Tetrahedron Lett 1979;24:2251-2.
21. Campbell RC. Statistics for biologists. London: Cambridge Univ Press, 1974:6-12.
22. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, et al. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res 1995;55: 1464-72.
23. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons, 1986.
24. Dunnett CW. A multiple comparisons procedure for comparing several treatments with a control. J Am Stat Assoc 1955;60:573-83.
25. Fiala ES, Joseph C, Sohn OS, El-Bayoumy K, Reddy BS. Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 1991;51: 2826-30.
26. Rotruck JT, Pope AL, Ganther HE. Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-90.
27. Bird RP, Schneider R, Stamp D, Bruce WR. Effect of dietary calcium and cholic acid on the proliferative indices of murine colonic epithelium. Carcinogenesis 1986;7:1657-61.
28. Wargovich MJ, Eng VW, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett 1984;23:253-8.
29. Newmark HL, Lipkin M. Calcium, vitamin D, and colon cancer. Cancer Res 1992;52(7 Suppl):2067s-70s.
30. Kulkarni N, Zang E, Kelloff G, Reddy BS. Effect of chemopreventive agents piroxicam and D,L-α-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1992;13:995-1000.
31. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994;107:3569-77.
32. Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 1995;55:979-83.
33. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth; development and differentiation of both tumour and normal cells. Anticancer Res 1990;10:1153-9.
34. Elder DJ, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 1996; 56:2273-6.
35. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996;56:2556-60.
36. Van Duuren BL, Goldschmidt BM. Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. J Natl Cancer Inst 1976;56: 1237-42.
37. Thompson HJ, Wilson A, Lu J, Singh M, Liang C, Upadhyaya P, et al. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 1994;15:183-6.
38. Tillotson JK. Upadhyaya P, Ronai Z. Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis 1994;15: 607-10.